Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Saloner

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Plos One|October 6, 2020
Access and enrollment in safety net programs in the wake of COVID-19: A national cross-sectional surveyBrendan Saloner, Sarah E Gollust, Colin Planalp, et al.
Health Economics|January 28, 2017
Access to Health Insurance and Utilization of Substance Use Disorder Treatment: Evidence from the Affordable Care Act Dependent Coverage ProvisionBrendan Saloner, Yaa Akosa Antwi, Johanna Catherine Maclean, et al.
Addiction (Abingdon, England)|January 21, 2017
Non-buprenorphine opioid utilization among patients using buprenorphineMatthew Daubresse, Brendan Saloner, Harold A Pollack, et al.
Health Affairs (Project Hope)|April 2, 2019
The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West VirginiaBrendan Saloner, Rachel Landis, Bradley D Stein, et al.
Medical Care|August 13, 2019
Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use DisorderHsien-Yen Chang, Matthew Daubresse, Brendan Saloner, et al.
Health Affairs (Project Hope)|February 1, 2021
Institutions For Mental Diseases Medicaid Waivers: Impact On Payments For Substance Use Treatment FacilitiesJohanna Catherine Maclean, Hefei Wen, Kosali I Simon, et al.
JAMIA Open|May 16, 2022
Comparing person-level matching algorithms to identify risk across disparate datasets among patients with a controlled substance prescription: retrospective analysisLindsey M Ferris, Jonathan P Weiner, Brendan Saloner, et al.
Health Services Research|January 9, 2024
Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorderJason B Gibbons, Wenshu Li, Elizabeth A Stuart, et al.
Drug and Alcohol Dependence|July 19, 2017
Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sampleNoa Krawczyk, Kenneth A Feder, Michael I Fingerhood, et al.
Journal of Substance Abuse Treatment|July 24, 2018
Is screening and intervention associated with treatment receipt among individuals with alcohol use disorder? Evidence from a national surveySachini N Bandara, Hillary Samples, Rosa M Crum, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Plos One|October 6, 2020
Access and enrollment in safety net programs in the wake of COVID-19: A national cross-sectional surveyBrendan Saloner, Sarah E Gollust, Colin Planalp, et al.
Health Economics|January 28, 2017
Access to Health Insurance and Utilization of Substance Use Disorder Treatment: Evidence from the Affordable Care Act Dependent Coverage ProvisionBrendan Saloner, Yaa Akosa Antwi, Johanna Catherine Maclean, et al.
Addiction (Abingdon, England)|January 21, 2017
Non-buprenorphine opioid utilization among patients using buprenorphineMatthew Daubresse, Brendan Saloner, Harold A Pollack, et al.
Health Affairs (Project Hope)|April 2, 2019
The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West VirginiaBrendan Saloner, Rachel Landis, Bradley D Stein, et al.
Medical Care|August 13, 2019
Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use DisorderHsien-Yen Chang, Matthew Daubresse, Brendan Saloner, et al.
Health Affairs (Project Hope)|February 1, 2021
Institutions For Mental Diseases Medicaid Waivers: Impact On Payments For Substance Use Treatment FacilitiesJohanna Catherine Maclean, Hefei Wen, Kosali I Simon, et al.
JAMIA Open|May 16, 2022
Comparing person-level matching algorithms to identify risk across disparate datasets among patients with a controlled substance prescription: retrospective analysisLindsey M Ferris, Jonathan P Weiner, Brendan Saloner, et al.
Health Services Research|January 9, 2024
Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorderJason B Gibbons, Wenshu Li, Elizabeth A Stuart, et al.
Drug and Alcohol Dependence|July 19, 2017
Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sampleNoa Krawczyk, Kenneth A Feder, Michael I Fingerhood, et al.
Journal of Substance Abuse Treatment|July 24, 2018
Is screening and intervention associated with treatment receipt among individuals with alcohol use disorder? Evidence from a national surveySachini N Bandara, Hillary Samples, Rosa M Crum, et al.
Pageof 20